EICHORCondition: Metabolic Acidosis · Chronic Kidney Disease · Sponsor: Tricida, Inc.
The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Estimated glomerular filtration rate (eGFR) 20 - 40 mL/min/1.73m\^2. * Serum bicarbonate 12 - 20 mEq/L. * On maximum tolerated dose of ACE inhibitor and/or ARB. Exclusion Criteria: * Acute metabolic acidosis. * Anticipated dialysis or kidney transplant within 6 months. * Recent acute kidney injury.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Investigative Site 4136 | Azusa, California, United States | — |
| Investigative Site 4148 | Denver, Colorado, United States | — |
| Investigative Site 4157 | Boca Raton, Florida, United States | — |
| Investigative Site 4146 | Bradenton, Florida, United States | — |
| Investigative Site 4102 | Coral Springs, Florida, United States | — |
| Investigative Site 4153 | Fort Lauderdale, Florida, United States | — |
| Investigative Site 4122 | Hollywood, Florida, United States | — |
| Investigative Site 4123 | Hollywood, Florida, United States | — |
| Investigative Site 4104 | Miami, Florida, United States | — |
| Investigative Site 4130 | Miami Lakes, Florida, United States | — |
| Investigative Site 4116 | Port Charlotte, Florida, United States | — |
| Investigative Site 4152 | Tampa, Florida, United States | — |
+ 191 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03710291